Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01227954 · ClinicalTrials.gov registry record · Phase 2
Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase 2 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 113
- Enrollment target
NCT01227954 is a Phase 2 study that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 113 participants.
The verdict
NCT01227954, a Phase 2 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 113 participants
- Enrollment target
Study Summary
RATIONALE: Radiation therapy uses high energy x-rays to kill tumor cells. PURPOSE: This phase II trial is studying how well avoiding the hippocampus during whole-brain radiation therapy works in treating patients with brain metastases.
Interventions
- RADIATION intensity-modulated radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2011-03 |
| Est. Completion | 2016-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01227954
The ClinicalTrials.gov registry entry for NCT01227954 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which intensity-modulated radiation therapy is the first listed.
NCT01227954 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01227954 about?
NCT01227954 is a clinical study titled "Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases". RATIONALE: Radiation therapy uses high energy x-rays to kill tumor cells. PURPOSE: This phase II trial is studying how well avoiding the hippocampus during whole-brain radiation therapy works in treating patients with brain metastases.
What is the current status of trial NCT01227954?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 113 participants. The study started on 2011-03. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01227954?
The interventions under investigation include: intensity-modulated radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT01227954?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.